Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 637,344 | 309,622 | 386,035 | 365,963 | 988,785 |
| Marketable Securities | 440,000 | 515,000 | 215,000 | 60,000 | N/A |
| Receivables | 355,987 | 263,838 | 224,129 | 234,244 | 209,685 |
| Inventories | 78,608 | 52,956 | 43,245 | 34,051 | 19,451 |
| Other current assets | 78,895 | 67,572 | 76,686 | 29,310 | 19,047 |
| TOTAL | $1,630,268 | $1,234,005 | $968,277 | $748,069 | $1,257,667 |
| Non-Current Assets | |||||
| PPE Net | 131,506 | 200,358 | 170,080 | 107,490 | 85,572 |
| Intangibles | 3,360,995 | 3,658,964 | 3,926,664 | 3,905,811 | 1,842,745 |
| Other Non-Current Assets | 416,128 | 110,164 | 58,651 | 38,857 | 146,628 |
| TOTAL | $3,908,629 | $3,969,486 | $4,155,395 | $4,052,158 | $2,074,945 |
| Total Assets | $5,538,897 | $5,203,491 | $5,123,672 | $4,800,227 | $3,332,612 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 33,387 | 33,387 | 40,605 | 36,094 | 37,587 |
| Accounts payable and accrued liabilities | 45,732 | 40,602 | 24,368 | 22,415 | 21,807 |
| Accrued Expenses | 269,686 | 264,887 | 198,779 | 193,268 | 164,070 |
| TOTAL | $364,490 | $345,487 | $293,947 | $257,406 | $226,642 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,573,870 | 1,563,025 | 1,540,433 | 1,993,531 | 1,150,857 |
| Deferred Revenues | 4,720 | 5,414 | 8,618 | 1,123 | 1,370 |
| Other Non-Current Liabilities | 260,600 | 218,879 | 176,608 | 112,617 | 69,254 |
| TOTAL | $2,063,426 | $2,100,582 | $2,116,628 | $2,665,482 | $1,507,324 |
| Total Liabilities | $2,427,916 | $2,446,069 | $2,410,575 | $2,922,888 | $1,733,966 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,133 | 57,056 | 59,803 | 59,742 | 61,185 |
| Common Shares | 61 | 61 | 61 | 61 | 61 |
| Retained earnings | 1,068,287 | 841,522 | 918,428 | 529,379 | 303,157 |
| Other shareholders' equity | -223,393 | -197,791 | -140,878 | -317,333 | -267,472 |
| TOTAL | $3,110,981 | $2,757,422 | $2,713,097 | $1,877,339 | $1,598,646 |
| Total Liabilities And Equity | $5,538,897 | $5,203,491 | $5,123,672 | $4,800,227 | $3,332,612 |